Longevium today announced plans to open its first international clinic in Bali in 2027, taking its Dubai-built model of physician-led longevity medicine into Southeast Asia. Developed in a joint venture with Nuanu founder Sergey Solonin, the clinic will serve patients travelling for personalised medical programmes and residents seeking long-term care.

Longevium’s ambition is to become one of the reasons people fly to Bali — and a trusted clinic for those who call the island home. The new location will anchor the group’s medical-tourism offering, with programmes that begin before the flight and continue after patients return home through Longevium’s digital platform. For residents, it will offer a doctor who knows their history and follows their health over time.

The expansion builds on three Dubai clinics that have served more than 30,000 patients. With an Abu Dhabi clinic and a research laboratory at Dubai Science Park also planned, Longevium is building beyond a network of clinics: an international medical group with its own research and technology capabilities.

Longevium began with a physician’s conviction that longevity should offer more than a shopping list of tests. Dr Ksenia Butova, MD, founded the group around the idea that one physician should be responsible for the whole patient journey, supported by advanced diagnostics and an AI platform designed to turn years of health data into decisions.

“Most of what is sold as longevity is a menu of tests,” said Dr Ksenia Butova, MD, Founder & CEO of Longevium. “Longevium stands for frontier medicine.” The approach puts the physician at the centre of a continuing relationship, with personalised protocols shaped around the patient rather than a fixed menu of treatments.

Bali is a deliberate choice. The island attracts people willing to invest in their health, while Longevium’s outpatient format allows a medical programme to fit around a stay — or everyday life — without a hospital admission or residential retreat. Memberships and dedicated access are planned for the Nuanu community.

The planned clinical offering combines advanced diagnostics and digital modelling with robotic phlebotomy, hyperbaric oxygen and personalised recovery protocols. Technology will support the physician’s judgement, with programmes built around each patient’s baseline. Regenerative therapies and newer methods will be introduced as they clear Indonesian regulatory review.

At Nuanu, the clinic will sit within a coastal community of residences, hotels, wellness spaces and creative studios at Nyanyi Beach, near Tanah Lot. The partnership brings together Nuanu’s premises, infrastructure and community with Longevium’s medical expertise and clinical model.

“Nuanu was built for people who choose how they live,” said Sergey Solonin, founder of Nuanu Creative City. He sees the clinic as part of everyday life for residents and a convenient destination for visiting patients.

Longevium’s digital platform is built by co-founder Sergey Shayakhmetov, who sold his previous AI medical company to a French pharmaceutical group before developing the technology that now runs Longevium’s clinics. “Longevity medicine is only as good as its data,” he said. “Our platform holds a patient’s whole medical history, protects the data with the same rigour as the medicine itself, and tells the physician what matters now. Patient records travel with the patients. Plan in Dubai, treat in Bali. Nothing gets lost when you fly home.”

Bali sits at the centre of two accelerating markets. Indonesia’s medical and wellness tourism sector is forecast to more than double over the next decade, while medical tourism across Asia-Pacific is projected to grow at more than 26% annually through 2030. Longevium is betting that the next generation of travellers will not choose between a destination and serious medicine — they will expect both.

The founding patient list for Longevium Bali is now open at www.longevium.id, offering priority booking for the opening months.